Cochlear's shares have lost 25.2 per cent of their value in 2020 amid a more severe market downturn.

Cochlear in raising, ASX warnings multiply

Medical tech firm Cochlear is seeking to eliminate liquidity risk by raising $850 million as the coronavirus pandemic delays elective surgeries across a growing number of countries.


(existing subscribers)

The password field is case sensitive.
Request new password

Share Price

Closing price for the last 90 trading days
Powered by Morningstar ®

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Powered by Morningstar ®

Total Shareholder Return as at 28/02/20

1 year TSR5 year TSR
322ndYowie Group0%-20%
374thWestoz Investment Company-5%6%
673rdSeafarms Group-50%-5%
818thSwift Media-80%-15%
671 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

$3.0m Issued
$15k Bought
$30k Bought
Total value as at the date of the transaction
Powered by Morningstar ®


57th↓Seafarms Group$24.8m
58th↑Swift Media$24.7m
61st↑Westoz Investment Company$21.3m
62nd↑Yowie Group$20.9m
198 listed industrial companies ranked by revenue.
Powered by Morningstar ®